home / stock / alpmf / alpmf news

ALPMF News and Press, Astellas Pharma Inc. From 02/27/26

Stock Information
Company Name: Astellas Pharma Inc.
Stock Symbol: ALPMF
Market: OTC
Website: astellas.com
Menu
Get ALPMF Alerts

News, Short Squeeze, Breakout and More Instantly...
ALPMF - Merck's Keytruda shows overall survival benefit in ovarian cancer

2026-02-27 11:38:24 ET More on Merck Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie Merck: Why Investors Should Remain Bullish Despite Patent Risks Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction F...
ALPMF - Bayer says Xofigo/Xtandi combo shows overall survival benefit in prostate cancer

2026-02-26 14:36:15 ET More on Bayer Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Seconda...

ALPMF - Biggest stock movers Tuesday: HIMS, VIR, CLVT, and more

2026-02-24 10:24:57 ET More on related stocks: Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript Vir Biote...

ALPMF - Biggest stock movers Tuesday: HIMS, VIR, and more

2026-02-24 05:01:57 ET More on related stocks: Vir Biotechnology, Inc. (VIR) Q4 2025 Earnings Call Transcript Vir Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript Vir Biote...
ALPMF - Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset

2026-02-23 17:39:48 ET More on Vir Biotechnology Vir Biotechnology: The Low-Down On The Readouts Ahead Vir Biotechnology, Inc. (VIR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Vir Biotechnology, Inc. (VIR) Presents at 44th Annual J.P. Morga...

ALPMF - China drug licensing deals surge nearly 10-fold in value since 2021

2026-02-19 13:31:04 ET More on AbbVie, AstraZeneca PLC, etc. Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game Pfizer: The Rebound Looks Unsustainable AbbVie: Dominating Immunology While Building Oncology Upside Merck posts n...

ALPMF - AstraZeneca, Bristol partner with Evinova to use AI in drug development

2026-02-18 10:30:44 ET More on AstraZeneca, Bristol Myers Squibb Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff AstraZeneca: Q4 Earnings Analysis - Ticks The Boxes, Upgrading To Buy AstraZeneca PLC (AZN) Q4 2025 Earnings Call Transcript Bris...
ALPMF - Genentech's Gazyva succeeds in phase 3 trial for primary membranous nephropathy

2026-02-17 11:20:53 ET More on Roche Roche Holding AG (RHHBY) Shareholder/Analyst Presentation Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript Genentech multiple sclerosis candidate fenebr...

ALPMF - Astellas Pharma ADR GAAP EPS of ¥185.20, revenue of ¥1601.32B; updates full-year forecast

2026-02-04 02:09:13 ET More on Astellas Pharma ADR Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Pfizer, Ast...

ALPMF - Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-12 21:16:01 ET Astellas Pharma Inc. (ALPMY) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 6:00 PM EST... Read the full article on Seeking Alpha For further details see: Astellas Pharma Inc. (ALPMY) Presents at 44th Annual J.P. Morgan Healthcare Confe...
Previous 10 Next 10